Vicarious Surgical appoints Stephen From as new CEO
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kiora Pharmaceuticals Inc (KPRX)
Kiora Pharmaceuticals Inc stock price live, this page displays NASDAQ KPRX stock exchange data. View the KPRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kiora Pharmaceuticals Inc real time stock price chart below.
What Is the Kiora Pharmaceuticals Inc Stock Price Today?
The Kiora Pharmaceuticals Inc stock price today is 2.540.
What Is the Stock Symbol for Kiora Pharmaceuticals Inc?
The stock symbol for Kiora Pharmaceuticals Inc is ""KPRX.""
What Stock Exchange Does Kiora Pharmaceuticals Inc Trade On?
Kiora Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Kiora Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Kiora Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KPRX quote. (ISIN: US49721T5074)
What Is the Kiora Pharmaceuticals Inc Stock Price Today?
The Kiora Pharmaceuticals Inc stock price today is 2.540.
What Is the Stock Symbol for Kiora Pharmaceuticals Inc?
The stock symbol for Kiora Pharmaceuticals Inc is ""KPRX.""
What Stock Exchange Does Kiora Pharmaceuticals Inc Trade On?
Kiora Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Kiora Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Kiora Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KPRX quote. (ISIN: US49721T5074)
NASDAQ
Currency in USD
2.540
-0.060(-2.31%)
Closed·
After Hours
2.480-0.060(-2.36%)
·
Fair Value
An estimate of a Kiora Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.510
2.630
52 wk Range
2.510
4.770
KPRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
More Info
Fair Value
An estimate of a Kiora Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.5102.630
52 wk Range
2.5104.770
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KPRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kiora Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
11.000
Upside
+333.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Vicarious Surgical names Stephen From as new CEO
- Investing.com
- Form 8K Kiora Pharmaceuticals Inc For: 4 June
- Investing.com
- Vicarious Surgical appoints Stephen From as new CEO
- Investing.com
- Vicarious Surgical names Stephen From as new CEO
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Kiora Pharmaceuticals Inc Company Profile
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, which is in phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; and KIO-101, an eye drop formulation for the treatment of ocular presentation of rheumatoid arthritis. It has strategic development and commercialization agreement with Théa Open Innovation for the development of KIO-301. The company operates in the United States, Austria, and Australia. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.
Compare KPRX to Peers and Sector
Metrics to compare | KPRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKPRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −1.3x | −0.5x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 0.3x | 1.0x | 2.6x | |
Price / LTM Sales | 386.6x | 2.9x | 3.3x | |
Upside (Analyst Target) | 333.1% | 53.6% | 45.1% | |
Fair Value Upside | Unlock | 4.8% | 7.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 11.000
(+333.07% Upside)
Earnings
Latest Release
May 09, 2025
EPS / Forecast
-0.52 / -0.09
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Kiora Pharmaceuticals Trade On?
Kiora Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Kiora Pharmaceuticals?
The stock symbol for Kiora Pharmaceuticals is "KPRX."
What Is the Kiora Pharmaceuticals Market Cap?
As of today, Kiora Pharmaceuticals market cap is 7.73M.
What Is Kiora Pharmaceuticals's Earnings Per Share (TTM)?
The Kiora Pharmaceuticals EPS (TTM) is -2.87.
From a Technical Analysis Perspective, Is KPRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kiora Pharmaceuticals Stock Split?
Kiora Pharmaceuticals has split 3 times.
How Many Employees Does Kiora Pharmaceuticals Have?
Kiora Pharmaceuticals has 12 employees.
What is the current trading status of Kiora Pharmaceuticals (KPRX)?
As of 04 Aug 2025, Kiora Pharmaceuticals (KPRX) is trading at a price of 2.54, with a previous close of 2.54. The stock has fluctuated within a day range of 2.51 to 2.63, while its 52-week range spans from 2.51 to 4.77.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.